This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEI810LS_L.jpg
In July, CureVac had filed a patent lawsuit against BioNTech over its use of mRNA technology, seeking fair compensation from the company and two subsidiaries for infringement of its intellectual properly rights.
Pfizer and BioNTech later filed a complaint with a U.S. district court, seeking a judgment that they did not infringe U.S. patents held by CureVac.
Pfizer and BioNTech are also facing patent infringement lawsuits from other companies.
Last month, rival mRNA vaccine maker Moderna (NASDAQ:MRNA) filed a patent lawsuit against the companies related to their COVID-19 shot.
